The first study, undertaken by the Early Genetics and Lifecourse Epidemiology research cohort (EAGLE), which includes Children of the 90s (ALSPAC) at the University of Bristol, involved almost 32,000 individuals from 16 studies worldwide.
The EAGLE study was conducted in two stages. The first compared 5,809 allergy sufferers with 9,875 non-allergy sufferers (controls). Allergy was assessed objectively by measuring allergen levels in blood or by a skin-prick test.
The second phase replicated the study in 6,145 independent allergy sufferers and 10,137 controls.
"Allergy is an important component of many diseases, including asthma, eczema and hay fever, which together account for a huge burden on patients and the health services. This is a very exciting time for allergy research," said Professor John Henderson from Children of the 90s, who was involved in the EAGLE study.
More From This Section
"Genetic discoveries have identified specific pathways of allergy development that are not shared with allergic diseases like asthma. Understanding these pathways could lead to eventual development of drugs that cure or prevent allergy rather than just suppressing its symptoms," Henderson said.
"One of the key features of this work is the demonstration that with a suitably sized study, the analysis of medically relevant questionnaire data alongside genetic variation has the potential to yield important information concerning the underlying biology of a complex outcome," said Dr Nic Timpson from Children of the 90s, who was involved in both studies.